# LORATADINE AND PSEUDOEPHEDRINE SULFATE
> **ANDA218017** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2024-05-14
## Drug
- **FDA Application Number:** ANDA218017
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORATADINE AND PSEUDOEPHEDRINE SULFATE
- **Generic name:** LORATADINE AND PSEUDOEPHEDRINE SULFATE
- **Active ingredients:** LORATADINE; PSEUDOEPHEDRINE SULFATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** BIONPHARMA
- **Manufacturer:** HEB
- **First approval:** 2024-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218017)
---
*MORVS · CC0 1.0*